Boston Scientific (BSX) EBITDA Margin Growth (1y) (2010 - 2026)
Boston Scientific (BSX) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 535.00 |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 257.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141.00 |
| Dec 31, 2025 | 81.00 |
| Sep 30, 2025 | 328.00 |
| Jun 30, 2025 | 356.00 |
| Mar 31, 2025 | 225.00 |
| Dec 31, 2024 | -88.00 |
| Sep 30, 2024 | -223.00 |
| Jun 30, 2024 | -166.00 |
| Mar 31, 2024 | 122.00 |
| Dec 31, 2023 | 328.00 |
| Sep 30, 2023 | 836.00 |
| Jun 30, 2023 | 124.00 |
| Mar 31, 2023 | 89.00 |
| Dec 31, 2022 | 664.00 |
| Sep 30, 2022 | -191.00 |
| Jun 30, 2022 | 452.00 |
| Mar 31, 2022 | 196.00 |
| Dec 31, 2021 | 391.00 |
| Sep 30, 2021 | 2,091.00 |
| Jun 30, 2021 | 1,206.00 |